Back to BIIB Stock Lookup

BIIB Related Analyst Ratings

May 20, 2013 04:43 PM Biogen's (BIIB) BG-12 Data Not Inflated

May 20, 2013 10:06 AM Biogen (BIIB) Weeks-6 TECFIDERA Scripts Continue to Ramp

May 13, 2013 09:41 AM Biogen's (BIIB) TECFIDERA Scripts Accelerating WoW

May 6, 2013 08:40 AM Scripts Data Indicates Biogen's (BIIB) Tecfidera Could Beat 2013 Estimates by $400M

May 1, 2013 07:20 AM Goldman Sachs Downgrades Biogen (BIIB) to Neutral, Removes from CL List

May 1, 2013 06:45 AM Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy

Apr 29, 2013 12:53 PM Deutsche Bank Sees Upside for Biogen's (BIIB) Tecfidera

Apr 26, 2013 08:03 AM Jefferies Lifts Numbers on Biogen (BIIB) Post Q1

Apr 25, 2013 02:00 PM Deutsche Bank Maintains Buy on Biogen (BIIB)

Apr 22, 2013 05:24 PM Deutsche Bank Raises Biogen (BIIB) Price Target to $240

Apr 22, 2013 12:59 PM Strong Biogen (BIIB) Tecfideara Sales Tied to Patient 'Warehousing'

Apr 22, 2013 08:48 AM Early Data Says Biogen's (BIIB) Tecfidera Doing Well - Analyst

Apr 12, 2013 09:00 AM BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy

Mar 28, 2013 09:12 AM Biogen (BIIB) Target Raised to $215 at Jefferies after Tecfidera Approved with Favorable Label

Mar 28, 2013 07:13 AM JMP Securities Starts Biogen (BIIB) at Market Outperform

Mar 27, 2013 05:43 PM What Next for Biogen (BIIB)? Anlaysts Weigh In

Mar 25, 2013 08:40 AM Jefferies Maintains Bullish Stance on Biogen (BIIB) after AAN Meeting

Mar 4, 2013 07:09 AM Elan Corp (ELN) Initiates New Dividend Program; Will Be Tied to Tysabri Performance

Feb 27, 2013 07:38 AM Canaccord Genuity Upgrades Biogen (BIIB) to Buy

Feb 8, 2013 06:53 AM Citi Upgrades Biogen (BIIB) to Buy

Feb 6, 2013 03:50 PM Deutsche Bank Boosts PT on Biogen (BIIB) to $170 on Tysabri Deal

Jan 15, 2013 06:49 AM BofA/Merrill Lynch Downgrades Biogen (BIIB) to Neutral

Jan 3, 2013 06:48 AM Piper Jaffray Downgrades Biogen (BIIB) to Neutral

Dec 18, 2012 07:14 AM Canaccord Genuity Starts Biogen (BIIB) at Hold

Dec 13, 2012 09:12 AM Goldman Sachs Resumes Biogen (BIIB) at Conviction Buy on Upcoming Drug Launches

Nov 21, 2012 10:27 AM Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded

Nov 21, 2012 07:25 AM Brean Capital Starts Biogen (BIIB) at Buy

Nov 9, 2012 09:45 AM Guggenheim Starts Biogen (BIIB) at Buy

Oct 4, 2012 05:04 PM Oppenheimer Downgrades Biogen (BIIB) to Perform

Sep 27, 2012 07:37 AM Jefferies Lifts Target on Biogen (BIIB) to $176, Hemophilia Data Adds To Valuation

Sep 26, 2012 11:36 AM Baxter (BAX) Smacked on Solid Results from Biogen's (BIIB) Hemophilia Drug

Sep 11, 2012 08:57 AM Cantor Fitzgerald Reiterates a 'Buy' on Sunesis Pharmaceuticals (SNSS); Market Potential for Vosaroxin

Sep 10, 2012 12:55 PM UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)

Sep 10, 2012 12:37 PM UPDATE: UBS Downgrades Biogen (BIIB) to Neutral; Risk/Reward Now Balanced

Sep 6, 2012 08:18 AM Leerink Swann Starts XenoPort (XNPT) at Outperform; Pipeline Attractive

Jul 25, 2012 01:29 PM UBS Maintains a 'Buy' on Biogen (BIIB); Key Takeaways from 2Q12

Jul 25, 2012 10:05 AM Jefferies Maintains a 'Buy' on Biogen (BIIB) on Strong Q2; Adjusting Numbers

Jul 23, 2012 07:41 AM Leerink Swann Starts Biogen (BIIB) at Outperform; Key to Fulfilling BG-12's Blockbuster Potential

Jul 6, 2012 02:01 PM Q2 Kickoff: Alcoa (AA) Investors to Focus on LME Prices, Downstream Ops, and China

Jul 5, 2012 10:47 AM Wells Fargo on Biogen (BIIB): Price Increases in MS Space Should Offer More Flexibility for BG-12

Jul 5, 2012 09:58 AM Elan Corp (ELN) Has Mutlipe Items Driving Action Today

May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium

May 10, 2012 12:26 PM Goldman Sachs Said Biogen's (BIIB) BG-12 Acceptance Should Alliaate Concerns

May 9, 2012 12:38 PM UBS Maintains a 'Buy' on Biogen (BIIB); Core Franchise Support Valuation; Pipeline Provides Upside Risk

May 2, 2012 02:47 PM Jefferies Increases Price Target in Biogen (BIIB)

May 2, 2012 07:55 AM Goldman Sachs Maintains Bullish Stance on Biogen (BIIB), Sees Room for Significant Upside

May 1, 2012 03:58 PM Baird Maintains a 'Neutral' on Biogen (BIIB); Still Prefer the Sidelines as Pipeline Remains The Focus

Apr 30, 2012 07:13 AM Deutsche Bank maintains a 'Buy' on Biogen Idec (BIIB); Hemophilia Survey Suggests Market Share Gains

Apr 23, 2012 08:06 AM Jefferies Maintains a 'Buy' on Biogen (BIIB); Favorable Gilenya Update

Apr 19, 2012 10:38 AM Baird Maintains a 'Neutral' on Biogen (NASDAQ: BIIB); Raising Estimates Ahead of Earnings

Back to BIIB Stock Lookup